DALLAS (WBAP/KLIF) – The Parkland Center for Clinical Innovation said on Tuesday that the Federal Government’s pause of the Johnson&Johnson COVID-19 vaccine is not expected to impact the target date for herd immunity in Dallas County.
According to PCCI, Dallas County has administered 61% Pfizer, 35% Moderna, and 4% J&J to date.
“We were progressing towards herd immunity at a rate of approximately 3% per week, which was ahead of initial predictions,” said PCCI CEO, Steve Miff. “While the allocations for J&J were scheduled to increase and the latest developments will pause those vaccinations likely for several weeks, we forecast that Dallas county will continue to make progress at 2-2.5% per week, which maintains the pace for mid-June.”
The FDA and CDC announced the pause Tuesday. Health authorities are investigating a possible connection between the J&J shot and blood clots in at least six women.
